HPC
BMY icon

HM Payson & Co’s Bristol-Myers Squibb BMY Stock Holding History

HM Payson & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.52M Sell
113,175
-767
-0.7% -$44K 0.09% 106
2026
Q1 		$6.91M Buy
113,942
+4,529
+4% +$264K 0.1% 99
2025
Q4 		$5.9M Buy
109,413
+14,921
+16% +$718K 0.08% 100
2025
Q3 		$4.26M Buy
94,492
+8,941
+10% +$418K 0.06% 116
2025
Q2 		$3.96M Sell
85,551
-7,163
-8% -$352K 0.06% 116
2025
Q1 		$5.65M Sell
92,714
-5,155
-5% -$300K 0.1% 98
2024
Q4 		$5.54M Buy
97,869
+7,583
+8% +$424K 0.09% 99
2024
Q3 		$4.67M Sell
90,286
-7,517
-8% -$353K 0.08% 113
2024
Q2 		$4.06M Sell
97,803
-4,913
-5% -$220K 0.07% 116
2024
Q1 		$5.57M Sell
102,716
-23,277
-18% -$1.19M 0.1% 103
2023
Q4 		$6.46M Sell
125,993
-90,270
-42% -$4.74M 0.13% 92
2023
Q3 		$12.6M Sell
216,263
-651,425
-75% -$39.9M 0.29% 65
2023
Q2 		$55.5M Sell
867,688
-246,133
-22% -$16.5M 1.25% 26
2023
Q1 		$77.2M Buy
1,113,821
+7,317
+0.7% +$516K 1.85% 16
2022
Q4 		$79.6M Buy
1,106,504
+107,063
+11% +$8.07M 1.98% 15
2022
Q3 		$71M Buy
999,441
+449,663
+82% +$32.6M 1.95% 12
2022
Q2 		$42.3M Buy
549,778
+73,688
+15% +$5.61M 1.09% 33
2022
Q1 		$34.8M Buy
476,090
+381,214
+402% +$25.6M 0.79% 41
2021
Q4 		$5.92M Sell
94,876
-1,596
-2% -$93.6K 0.13% 101
2021
Q3 		$5.71M Buy
96,472
+340
+0.4% +$22.4K 0.14% 99
2021
Q2 		$6.42M Sell
96,132
-132
-0.1% -$8.61K 0.16% 95
2021
Q1 		$6.08M Sell
96,264
-13
-0% -$809 0.16% 94
2020
Q4 		$5.97M Sell
96,277
-2,845
-3% -$175K 0.17% 98
2020
Q3 		$5.98M Sell
99,122
-16
-0% -$963 0.18% 93
2020
Q2 		$5.83M Buy
99,138
+80
+0.1% +$4.79K 0.2% 87
2020
Q1 		$5.52M Sell
99,058
-7,044
-7% -$431K 0.22% 80
2019
Q4 		$6.81M Buy
106,102
+7,378
+7% +$423K 0.22% 85
2019
Q3 		$5.01M Buy
98,724
+5,571
+6% +$262K 0.18% 92
2019
Q2 		$4.22M Sell
93,153
-2,002
-2% -$93.3K 0.15% 99
2019
Q1 		$4.54M Buy
+95,155
New +$4.74M 0.17% 96
2018
Q4 		– Sell
-74,745
Closed -$4.64M – 176
2018
Q3 		$4.64M Sell
74,745
-15,076
-17% -$895K 0.21% 90
2018
Q2 		$4.97M Buy
89,821
+106
+0.1% +$5.72K 0.21% 89
2018
Q1 		$5.67M Sell
89,715
-847
-0.9% -$54.5K 0.23% 86
2017
Q4 		$5.55M Buy
90,562
+1,514
+2% +$94.7K 0.22% 90
2017
Q3 		$5.68M Sell
89,048
-700
-0.8% -$40.9K 0.24% 85
2017
Q2 		$5M Sell
89,748
-700
-0.8% -$38.1K 0.23% 86
2017
Q1 		$4.92M Sell
90,448
-1,581
-2% -$86.7K 0.22% 88
2016
Q4 		$5.38M Sell
92,029
-1,070
-1% -$58.5K 0.26% 84
2016
Q3 		$5.02M Sell
93,099
-1,463
-2% -$94K 0.24% 82
2016
Q2 		$6.96M Sell
94,562
-1,060
-1% -$74.9K 0.35% 69
2016
Q1 		$6.11M Sell
95,622
-1,398
-1% -$88.2K 0.32% 72
2015
Q4 		$6.67M Buy
97,020
+4,748
+5% +$314K 0.34% 78
2015
Q3 		$5.46M Buy
92,272
+871
+1% +$55.3K 0.3% 78
2015
Q2 		$6.08M Buy
91,401
+156
+0.2% +$10.3K 0.3% 82
2015
Q1 		$5.88M Sell
91,245
-2,318
-2% -$145K 0.29% 82
2014
Q4 		$5.52M Sell
93,563
-3,000
-3% -$169K 0.27% 84
2014
Q3 		$4.94M Buy
96,563
+11
+0% +$549 0.25% 88
2014
Q2 		$4.68M Buy
96,552
+280
+0.3% +$13.8K 0.24% 87
2014
Q1 		$5M Sell
96,272
-3,762
-4% -$200K 0.26% 86
2013
Q4 		$5.32M Buy
100,034
+1,176
+1% +$59.9K 0.28% 84
2013
Q3 		$4.58M Sell
98,858
-6,273
-6% -$275K 0.27% 87
2013
Q2 		$4.7M Buy
+105,131
New +$4.56M 0.28% 83

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

HM Payson & Co's BMY Position: Q2 2026 in Review

HM Payson & Co reduced its Bristol-Myers Squibb (BMY) stake by 0.67% in Q2 2026, selling an estimated $44K and leaving 113,175 shares worth $6.52M. The position accounts for 0.09% of the portfolio, ranked #106.

HM Payson & Co first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $79.6M in Q4 2022. 814 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • HM Payson & Co held 113,175 shares of Bristol-Myers Squibb worth $6.52M as of Q2 2026.
  • HM Payson & Co sold 767 Bristol-Myers Squibb shares in Q2 2026, an estimated $44K.
  • Bristol-Myers Squibb made up 0.09% of HM Payson & Co's portfolio in Q2 2026, its #106 holding.
  • HM Payson & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • HM Payson & Co's Bristol-Myers Squibb position peaked at $79.6M in Q4 2022.
  • 814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.